501 related articles for article (PubMed ID: 15086910)
1. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.
Doi K; Suzuki Y; Nakao A; Fujita T; Noiri E
Kidney Int; 2004 May; 65(5):1714-23. PubMed ID: 15086910
[TBL] [Abstract][Full Text] [Related]
2. Edaravone reduces ischemia-reperfusion injury mediators in rat liver.
Taniguchi M; Uchinami M; Doi K; Yoshida M; Sasaki H; Tamagawa K; Horiuchi T; Tanaka K
J Surg Res; 2007 Jan; 137(1):69-74. PubMed ID: 17064733
[TBL] [Abstract][Full Text] [Related]
3. Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiting lipid peroxidation in rat.
Yagi H; Horinaka S; Matsuoka H
J Cardiovasc Pharmacol; 2005 Jul; 46(1):46-51. PubMed ID: 15965354
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of edaravone against renal ischemia/reperfusion injury and compared with ischemic postconditioning in rats.
Li Y; Xia AZ; Xing SH
Yao Xue Xue Bao; 2010 Jul; 45(7):840-8. PubMed ID: 20931780
[TBL] [Abstract][Full Text] [Related]
5. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.
Chatterjee PK; Cuzzocrea S; Brown PA; Zacharowski K; Stewart KN; Mota-Filipe H; Thiemermann C
Kidney Int; 2000 Aug; 58(2):658-73. PubMed ID: 10916089
[TBL] [Abstract][Full Text] [Related]
6. Edaravone, a newly developed radical scavenger, protects against ischemia-reperfusion injury of the small intestine in rats.
Tomatsuri N; Yoshida N; Takagi T; Katada K; Isozaki Y; Imamoto E; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
Int J Mol Med; 2004 Jan; 13(1):105-9. PubMed ID: 14654979
[TBL] [Abstract][Full Text] [Related]
7. Electron spin resonance and spin trapping technique provide direct evidence that edaravone prevents acute ischemia-reperfusion injury of the liver by limiting free radical-mediated tissue damage.
Kono H; Woods CG; Maki A; Connor HD; Mason RP; Rusyn I; Fujii H
Free Radic Res; 2006 Jun; 40(6):579-88. PubMed ID: 16753835
[TBL] [Abstract][Full Text] [Related]
8. Edaravone protects against ischemia/reperfusion-induced oxidative damage to mitochondria in rat liver.
Okatani Y; Wakatsuki A; Enzan H; Miyahara Y
Eur J Pharmacol; 2003 Mar; 465(1-2):163-70. PubMed ID: 12650846
[TBL] [Abstract][Full Text] [Related]
9. A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusion.
Chiazza F; Chegaev K; Rogazzo M; Cutrin JC; Benetti E; Lazzarato L; Fruttero R; Collino M
Oxid Med Cell Longev; 2015; 2015():804659. PubMed ID: 25834700
[TBL] [Abstract][Full Text] [Related]
10. Edaravone inhibits lipid peroxidation in neonatal hypoxic-ischemic rats: an in vivo microdialysis study.
Noor JI; Ueda Y; Ikeda T; Ikenoue T
Neurosci Lett; 2007 Feb; 414(1):5-9. PubMed ID: 17280782
[TBL] [Abstract][Full Text] [Related]
11. Edaravone (MCI-186), a free radical scavenger, attenuates retinal ischemia/reperfusion injury in rats.
Song Y; Gong YY; Xie ZG; Li CH; Gu Q; Wu XW
Acta Pharmacol Sin; 2008 Jul; 29(7):823-8. PubMed ID: 18565280
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes.
Yamawaki M; Sasaki N; Shimoyama M; Miake J; Ogino K; Igawa O; Tajima F; Shigemasa C; Hisatome I
Br J Pharmacol; 2004 Jun; 142(3):618-26. PubMed ID: 15148265
[TBL] [Abstract][Full Text] [Related]
13. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
[TBL] [Abstract][Full Text] [Related]
14. MCI-186 (edaravone), a free radical scavenger, attenuates ischemia-reperfusion injury and activation of phospholipase A(2) in an isolated rat lung model after 18 h of cold preservation.
Reyes YA; Shimoyama T; Akamatsu H; Sunamori M
Eur J Cardiothorac Surg; 2006 Mar; 29(3):304-11. PubMed ID: 16427299
[TBL] [Abstract][Full Text] [Related]
15. [Research and development of the free radical scavenger edaravone as a neuroprotectant].
Watanabe T; Tanaka M; Watanabe K; Takamatsu Y; Tobe A
Yakugaku Zasshi; 2004 Mar; 124(3):99-111. PubMed ID: 15049127
[TBL] [Abstract][Full Text] [Related]
16. Edaravone attenuates hydroxyl radical stress and augmented angiotensin II response in diabetic rats.
Saini AK; Patel RJ; Sharma SS; H S AK
Pharmacol Res; 2006 Jul; 54(1):6-10. PubMed ID: 16545576
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of edaravone for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb.
Hori K; Tsujii M; Iino T; Satonaka H; Uemura T; Akeda K; Hasegawa M; Uchida A; Sudo A
BMC Musculoskelet Disord; 2013 Mar; 14():113. PubMed ID: 23530927
[TBL] [Abstract][Full Text] [Related]
18. Edaravone enhances the viability of ischemia/reperfusion flaps.
Zhang DY; Kang SS; Zhang ZW; Wu R
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):51-56. PubMed ID: 28224430
[TBL] [Abstract][Full Text] [Related]
19. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain.
Zhang N; Komine-Kobayashi M; Tanaka R; Liu M; Mizuno Y; Urabe T
Stroke; 2005 Oct; 36(10):2220-5. PubMed ID: 16166574
[TBL] [Abstract][Full Text] [Related]
20. Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.
Zhang P; Li W; Li L; Wang N; Li X; Gao M; Zheng J; Lei S; Chen X; Lu H; Liu Y
Neuroscience; 2012 Jan; 201():297-306. PubMed ID: 22116052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
